Therapeutic intervention (pirfenidone+5‐azacytidine or pirfenidone+cantharidin) sensitizes IPF fibroblasts to BAG3‐mediated autophagy. The gene discussed is BAG3; the disease is idiopathic interstitial pneumonia.